Third-Party Tested ≥98% HPLC Purity — USA Shipped

Neuropeptides Research Guide

DSIP: Mechanism, Handling & Research Guide

Also known as: DSIP, Delta Sleep-Inducing Peptide, Delta-sleep-inducing peptide, Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, WAGGDASGE

Key Facts

DSIP is a neuropeptides research peptide. Delta sleep-inducing peptide for sleep and cognitive research. It is supplied as a lyophilized powder for laboratory and in-vitro research use only — not for human consumption.

Classification Endogenous neuromodulatory nonapeptide
Research Half-Life Not well characterized - early reports describe an unusually labile peptide with rapid plasma clearance; no consistent value is established in the literature
Form Lyophilized powder
Research Category Neuropeptides

What is DSIP?

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, first isolated from rabbit cerebral venous blood during induced sleep by Schoenenberger and Monnier in 1977. DSIP modulates sleep architecture by promoting delta wave (slow-wave) sleep patterns through interactions with multiple neurotransmitter systems, including GABAergic, glutamatergic, and opioidergic pathways. It also influences hypothalamic-pituitary axis regulation, affecting cortisol and growth hormone secretion patterns. Studies published in Peptides demonstrated that DSIP use normalized disturbed sleep patterns in animal models of chronic stress without producing the sedation or rebound effects associated with classical hypnotic agents. Research by Graf and Kastin (1986) in Neuroscience & Biobehavioral Reviews characterized DSIP's ability to cross the blood-brain barrier and its unusually long biological half-life relative to other neuropeptides. Additional investigations have indicated stress-protective effects, with DSIP reducing corticotropin levels and modulating the hypothalamic stress response. Unlike pharmaceutical sleep aids such as benzodiazepines or Z-drugs, DSIP does not directly suppress CNS activity. Instead, research suggests it normalizes sleep architecture, making it of interest for studying physiological rather than pharmacological sleep regulation. Compared to melatonin, DSIP operates through fundamentally different mechanisms, targeting delta wave promotion rather than circadian rhythm entrainment. Store lyophilized DSIP at -20°C, protected from light and moisture. Reconstitute with bacteriostatic water and refrigerate at 2-8°C, using within 4 weeks. DSIP is studied by sleep researchers, neuroendocrinologists, and stress physiologists investigating non-pharmacological approaches to sleep architecture restoration.

DSIP Research Applications

In published and preclinical research, DSIP has been studied across the following areas:

  • Sleep regulation studies
  • Cognition and neuroprotection research
  • Stress response modulation
  • Circadian rhythm research

DSIP in Research: Study Context

DSIP is a nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) first isolated from cerebral venous blood of sleeping rabbits; the published literature is older and comparatively thin, describing associations with slow-wave (delta) sleep, neuroendocrine effects on the hypothalamic-pituitary axis, and stress-related corticosteroid modulation, though findings are inconsistent and mechanistic understanding remains limited (Graf & Kastin, 1986; Schneider-Helmert et al., 1987). Evidence is preliminary and not conclusive. For in-vitro and laboratory research use only - not FDA-approved and no human concentration is provided here. Reconstitute the lyophilized 15mg peptide with bacteriostatic water to a defined concentration of 2.5 mg/mL for laboratory handling, and confirm identity and purity against the primary literature and the lot-specific Certificate of Analysis (COA).

How DSIP Compares

Researchers frequently evaluate DSIP alongside related compounds:

  • DSIP vs Pinealon — Both are studied in sleep/circadian and neuro contexts, but DSIP is a nonapeptide reported to act on neurotransmitter and HPA-axis signaling, whereas Pinealon is a Khavinson tripeptide bioregulator proposed to act on gene expression - and Pinealon's literature is likewise limited.
  • DSIP vs Epithalon — Epithalon (AEDG) is a pineal-derived tetrapeptide bioregulator studied for telomerase/circadian effects via gene regulation; DSIP is a distinct nonapeptide tied to delta-sleep neuromodulation rather than the bioregulator mechanism.

DSIP — Frequently Asked Questions

What does the published literature say DSIP does?
Older research literature associates DSIP with promotion of slow-wave (delta) sleep and with neuroendocrine effects, including modulation of stress-axis hormone release in animal and limited human studies (Graf & Kastin, 1986). The evidence base is thin and findings are inconsistent, so any characterization should be treated as preliminary and confined to research contexts; no therapeutic claim is made.
How strong is the evidence behind DSIP?
Compared with peptides like Thymosin Alpha-1 or VIP, DSIP has a limited and dated literature with inconsistent replication and an incompletely defined mechanism. Researchers should weight conclusions accordingly, reference the primary sources directly, and design appropriately controlled in-vitro experiments rather than extrapolating from sparse data.
What is DSIP's half-life?
Not well characterized. Early reports describe DSIP as metabolically labile with rapid clearance, and no consistent half-life value is established. Stability should be determined empirically in the researcher's own system, and material identity confirmed against the lot Certificate of Analysis (COA).
Is DSIP legal to buy for research?
DSIP is sold in the United States as a research chemical for laboratory and in-vitro use only. It is not approved by the FDA for human use and is not sold for human consumption. Researchers are responsible for compliance with all applicable federal, state, and institutional regulations.
Does DSIP come with a Certificate of Analysis?
Yes. Every batch of DSIP from Elyte Peptides ships with a third-party Certificate of Analysis (COA) documenting identity and HPLC purity (≥98%), so research results can be traced to a verified lot.
What is DSIP and how does it work?
DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) first isolated from rabbit brain tissue. It acts on multiple neurotransmitter systems including GABA, serotonin, and the hypothalamic-pituitary axis. In preclinical models, DSIP has been observed to promote delta-wave (slow-wave) sleep, modulate cortisol secretion patterns, and exhibit stress-protective properties through endocrine regulation.
What research has been done on DSIP?
DSIP was discovered by Schoenenberger and Monnier (published in Proceedings of the National Academy of Sciences, 1977). Clinical studies in Switzerland demonstrated improved sleep onset and delta-wave sleep duration in insomnia patients. Research in Peptides journal showed DSIP's ability to normalize disturbed circadian cortisol patterns. Additional studies have explored its analgesic properties, opioid withdrawal support, and stress resilience in animal models.
How does DSIP compare to Pinealon?
Both peptides are studied for brain and sleep-related research, but they work differently. DSIP acts directly on neurotransmitter systems (GABA, serotonin) and the hypothalamic-pituitary axis to induce delta-wave sleep patterns. Pinealon works as a bioregulator that modulates gene expression in brain tissue, influencing serotonin synthesis and circadian rhythms indirectly through DNA interaction. DSIP has a more direct pharmacological effect on sleep architecture.

Research References

  1. Graf MV, Kastin AJ. Delta-sleep-inducing peptide (DSIP): an update. Peptides. 1986.
  2. Schneider-Helmert D, et al. The use of DSIP (delta sleep-inducing peptide) in the correction of phase-shifted insomnia. Dtsch Med Wochenschr. 1987.
All research guides